Fig. 2
From: Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

Adjusted restricted cubic spline plot of the hazard ratio of MACE against PCSK9 levels
From: Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Adjusted restricted cubic spline plot of the hazard ratio of MACE against PCSK9 levels